A Study of AT1001 (Migalastat Hydrochloride) in Participants With Fabry Disease
Clinical trial NCT00214500 · COMPLETED
Trial details
- NCT number
- NCT00214500
- Sponsor
- Amicus Therapeutics
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-01-02
- Primary completion
- 2008-01-29
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.